NRF2 inhibitors such as isoorientin [54], qingrehuoxue formula [55], ginkgetin [53], and brusatol [51] all have shown ferroptosis inducing (Fig. 1) capability and reduced tumor volume in vivo. Here, NFE2L2 is linked to neoplasm.